nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—CYP3A4—Temozolomide—brain cancer	0.0708	0.342	CbGbCtD
Tacrolimus—CYP3A4—Lomustine—brain cancer	0.0602	0.291	CbGbCtD
Tacrolimus—CYP3A5—Etoposide—brain cancer	0.0373	0.18	CbGbCtD
Tacrolimus—ABCB1—Etoposide—brain cancer	0.0243	0.117	CbGbCtD
Tacrolimus—PPP3CA—pons—brain cancer	0.018	0.101	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—brain cancer	0.0148	0.0829	CbGeAlD
Tacrolimus—CYP3A4—Etoposide—brain cancer	0.0145	0.0702	CbGbCtD
Tacrolimus—PPP3CA—ganglion—brain cancer	0.0092	0.0516	CbGeAlD
Tacrolimus—PPP3CA—hindbrain—brain cancer	0.00697	0.0391	CbGeAlD
Tacrolimus—MTOR—blood vessel—brain cancer	0.0054	0.0303	CbGeAlD
Tacrolimus—ABCA5—telencephalon—brain cancer	0.00525	0.0295	CbGeAlD
Tacrolimus—MTOR—hindbrain—brain cancer	0.00515	0.0289	CbGeAlD
Tacrolimus—ABCA5—gonad—brain cancer	0.00438	0.0246	CbGeAlD
Tacrolimus—ABCA5—pituitary gland—brain cancer	0.00428	0.024	CbGeAlD
Tacrolimus—ABCA5—medulla oblongata—brain cancer	0.00413	0.0231	CbGeAlD
Tacrolimus—PPP3CA—brainstem—brain cancer	0.004	0.0224	CbGeAlD
Tacrolimus—ABCA5—midbrain—brain cancer	0.00377	0.0212	CbGeAlD
Tacrolimus—ABCA5—spinal cord—brain cancer	0.00368	0.0206	CbGeAlD
Tacrolimus—PPP3CA—telencephalon—brain cancer	0.00355	0.0199	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—brain cancer	0.00331	0.0186	CbGeAlD
Tacrolimus—ABCA5—head—brain cancer	0.00327	0.0183	CbGeAlD
Tacrolimus—ABCA5—central nervous system—brain cancer	0.00299	0.0167	CbGeAlD
Tacrolimus—MTOR—brainstem—brain cancer	0.00295	0.0166	CbGeAlD
Tacrolimus—ABCA5—cerebellum—brain cancer	0.00292	0.0164	CbGeAlD
Tacrolimus—PPP3CA—pituitary gland—brain cancer	0.00289	0.0162	CbGeAlD
Tacrolimus—PPP3CA—medulla oblongata—brain cancer	0.00279	0.0156	CbGeAlD
Tacrolimus—MTOR—telencephalon—brain cancer	0.00262	0.0147	CbGeAlD
Tacrolimus—PPP3CA—midbrain—brain cancer	0.00255	0.0143	CbGeAlD
Tacrolimus—PPP3CA—spinal cord—brain cancer	0.00249	0.0139	CbGeAlD
Tacrolimus—ABCA5—brain—brain cancer	0.00237	0.0133	CbGeAlD
Tacrolimus—FKBP1A—telencephalon—brain cancer	0.00236	0.0132	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—brain cancer	0.00224	0.0125	CbGeAlD
Tacrolimus—PPP3CA—head—brain cancer	0.00221	0.0124	CbGeAlD
Tacrolimus—MTOR—gonad—brain cancer	0.00219	0.0123	CbGeAlD
Tacrolimus—MTOR—pituitary gland—brain cancer	0.00213	0.012	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—brain cancer	0.00202	0.0113	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—brain cancer	0.00197	0.0111	CbGeAlD
Tacrolimus—FKBP1A—gonad—brain cancer	0.00197	0.011	CbGeAlD
Tacrolimus—FKBP1A—pituitary gland—brain cancer	0.00192	0.0108	CbGeAlD
Tacrolimus—FKBP1A—medulla oblongata—brain cancer	0.00185	0.0104	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—brain cancer	0.00184	0.0103	CbGeAlD
Tacrolimus—MTOR—spinal cord—brain cancer	0.00184	0.0103	CbGeAlD
Tacrolimus—FKBP1A—midbrain—brain cancer	0.00169	0.00949	CbGeAlD
Tacrolimus—MTOR—endocrine gland—brain cancer	0.00165	0.00927	CbGeAlD
Tacrolimus—FKBP1A—spinal cord—brain cancer	0.00165	0.00926	CbGeAlD
Tacrolimus—MTOR—head—brain cancer	0.00163	0.00915	CbGeAlD
Tacrolimus—PPP3CA—brain—brain cancer	0.0016	0.00898	CbGeAlD
Tacrolimus—MTOR—central nervous system—brain cancer	0.00149	0.00835	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—brain cancer	0.00149	0.00834	CbGeAlD
Tacrolimus—FKBP1A—head—brain cancer	0.00147	0.00823	CbGeAlD
Tacrolimus—MTOR—cerebellum—brain cancer	0.00146	0.00817	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—brain cancer	0.00134	0.00751	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—brain cancer	0.00131	0.00734	CbGeAlD
Tacrolimus—ORM1—spinal cord—brain cancer	0.00129	0.00725	CbGeAlD
Tacrolimus—MTOR—brain—brain cancer	0.00118	0.00663	CbGeAlD
Tacrolimus—ORM1—endocrine gland—brain cancer	0.00116	0.00653	CbGeAlD
Tacrolimus—ABCB1—blood vessel—brain cancer	0.00112	0.0063	CbGeAlD
Tacrolimus—FKBP1A—brain—brain cancer	0.00106	0.00597	CbGeAlD
Tacrolimus—ORM1—central nervous system—brain cancer	0.00105	0.00588	CbGeAlD
Tacrolimus—ALB—brain—brain cancer	0.00073	0.0041	CbGeAlD
Tacrolimus—CYP3A5—endocrine gland—brain cancer	0.000647	0.00363	CbGeAlD
Tacrolimus—ABCB1—telencephalon—brain cancer	0.000545	0.00306	CbGeAlD
Tacrolimus—CYP3A4—endocrine gland—brain cancer	0.000486	0.00272	CbGeAlD
Tacrolimus—ABCB1—gonad—brain cancer	0.000455	0.00255	CbGeAlD
Tacrolimus—ABCB1—pituitary gland—brain cancer	0.000444	0.00249	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—brain cancer	0.000438	0.00246	CbGeAlD
Tacrolimus—ABCB1—medulla oblongata—brain cancer	0.000428	0.0024	CbGeAlD
Tacrolimus—Fatigue—Procarbazine—brain cancer	0.000401	0.000936	CcSEcCtD
Tacrolimus—Haemoglobin—Temozolomide—brain cancer	0.000398	0.000929	CcSEcCtD
Tacrolimus—Malaise—Hydroxyurea—brain cancer	0.000398	0.000929	CcSEcCtD
Tacrolimus—Constipation—Procarbazine—brain cancer	0.000398	0.000929	CcSEcCtD
Tacrolimus—Pain—Procarbazine—brain cancer	0.000398	0.000929	CcSEcCtD
Tacrolimus—Haemorrhage—Temozolomide—brain cancer	0.000396	0.000924	CcSEcCtD
Tacrolimus—Hepatitis—Temozolomide—brain cancer	0.000396	0.000924	CcSEcCtD
Tacrolimus—Dysphagia—Etoposide—brain cancer	0.000396	0.000924	CcSEcCtD
Tacrolimus—Leukopenia—Hydroxyurea—brain cancer	0.000395	0.000922	CcSEcCtD
Tacrolimus—Visual impairment—Carmustine—brain cancer	0.000395	0.000922	CcSEcCtD
Tacrolimus—Hallucination—Temozolomide—brain cancer	0.000394	0.000919	CcSEcCtD
Tacrolimus—Hypoaesthesia—Temozolomide—brain cancer	0.000394	0.000919	CcSEcCtD
Tacrolimus—Pharyngitis—Temozolomide—brain cancer	0.000393	0.000917	CcSEcCtD
Tacrolimus—ABCB1—midbrain—brain cancer	0.000392	0.0022	CbGeAlD
Tacrolimus—Urinary tract disorder—Temozolomide—brain cancer	0.000391	0.000913	CcSEcCtD
Tacrolimus—Oedema peripheral—Temozolomide—brain cancer	0.00039	0.00091	CcSEcCtD
Tacrolimus—Connective tissue disorder—Temozolomide—brain cancer	0.000389	0.000908	CcSEcCtD
Tacrolimus—Urethral disorder—Temozolomide—brain cancer	0.000388	0.000906	CcSEcCtD
Tacrolimus—Sweating increased—Etoposide—brain cancer	0.000386	0.0009	CcSEcCtD
Tacrolimus—Feeling abnormal—Procarbazine—brain cancer	0.000384	0.000895	CcSEcCtD
Tacrolimus—Eye disorder—Carmustine—brain cancer	0.000383	0.000894	CcSEcCtD
Tacrolimus—Convulsion—Hydroxyurea—brain cancer	0.000383	0.000892	CcSEcCtD
Tacrolimus—ABCB1—spinal cord—brain cancer	0.000382	0.00214	CbGeAlD
Tacrolimus—Visual impairment—Temozolomide—brain cancer	0.000382	0.000891	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Procarbazine—brain cancer	0.000381	0.000888	CcSEcCtD
Tacrolimus—Flushing—Carmustine—brain cancer	0.000381	0.000887	CcSEcCtD
Tacrolimus—Pancytopenia—Etoposide—brain cancer	0.000376	0.000877	CcSEcCtD
Tacrolimus—Erythema multiforme—Temozolomide—brain cancer	0.000375	0.000874	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000373	0.000871	CcSEcCtD
Tacrolimus—Discomfort—Hydroxyurea—brain cancer	0.000371	0.000866	CcSEcCtD
Tacrolimus—Neutropenia—Etoposide—brain cancer	0.00037	0.000864	CcSEcCtD
Tacrolimus—Eye disorder—Temozolomide—brain cancer	0.00037	0.000864	CcSEcCtD
Tacrolimus—Urticaria—Procarbazine—brain cancer	0.00037	0.000863	CcSEcCtD
Tacrolimus—Tinnitus—Temozolomide—brain cancer	0.000369	0.000862	CcSEcCtD
Tacrolimus—Abdominal pain—Procarbazine—brain cancer	0.000368	0.000858	CcSEcCtD
Tacrolimus—Body temperature increased—Procarbazine—brain cancer	0.000368	0.000858	CcSEcCtD
Tacrolimus—Cardiac disorder—Temozolomide—brain cancer	0.000368	0.000858	CcSEcCtD
Tacrolimus—Flushing—Temozolomide—brain cancer	0.000368	0.000858	CcSEcCtD
Tacrolimus—Arrhythmia—Carmustine—brain cancer	0.000366	0.000854	CcSEcCtD
Tacrolimus—Alopecia—Carmustine—brain cancer	0.000362	0.000845	CcSEcCtD
Tacrolimus—Oedema—Hydroxyurea—brain cancer	0.00036	0.00084	CcSEcCtD
Tacrolimus—Angiopathy—Temozolomide—brain cancer	0.00036	0.000838	CcSEcCtD
Tacrolimus—Mental disorder—Carmustine—brain cancer	0.000359	0.000838	CcSEcCtD
Tacrolimus—Infection—Hydroxyurea—brain cancer	0.000358	0.000835	CcSEcCtD
Tacrolimus—Immune system disorder—Temozolomide—brain cancer	0.000358	0.000835	CcSEcCtD
Tacrolimus—Mediastinal disorder—Temozolomide—brain cancer	0.000357	0.000833	CcSEcCtD
Tacrolimus—Erythema—Carmustine—brain cancer	0.000357	0.000832	CcSEcCtD
Tacrolimus—Malnutrition—Carmustine—brain cancer	0.000357	0.000832	CcSEcCtD
Tacrolimus—Chills—Temozolomide—brain cancer	0.000356	0.000829	CcSEcCtD
Tacrolimus—Pneumonia—Etoposide—brain cancer	0.000355	0.000829	CcSEcCtD
Tacrolimus—Nervous system disorder—Hydroxyurea—brain cancer	0.000353	0.000824	CcSEcCtD
Tacrolimus—Infestation—Etoposide—brain cancer	0.000353	0.000824	CcSEcCtD
Tacrolimus—Infestation NOS—Etoposide—brain cancer	0.000353	0.000824	CcSEcCtD
Tacrolimus—Thrombocytopenia—Hydroxyurea—brain cancer	0.000353	0.000823	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00035	0.000817	CcSEcCtD
Tacrolimus—Alopecia—Temozolomide—brain cancer	0.00035	0.000817	CcSEcCtD
Tacrolimus—Skin disorder—Hydroxyurea—brain cancer	0.00035	0.000816	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Etoposide—brain cancer	0.000348	0.000812	CcSEcCtD
Tacrolimus—Renal failure—Etoposide—brain cancer	0.000347	0.00081	CcSEcCtD
Tacrolimus—Mental disorder—Temozolomide—brain cancer	0.000347	0.00081	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Etoposide—brain cancer	0.000346	0.000807	CcSEcCtD
Tacrolimus—Myocardial infarction—Etoposide—brain cancer	0.000346	0.000807	CcSEcCtD
Tacrolimus—Back pain—Carmustine—brain cancer	0.000345	0.000805	CcSEcCtD
Tacrolimus—Erythema—Temozolomide—brain cancer	0.000345	0.000804	CcSEcCtD
Tacrolimus—Malnutrition—Temozolomide—brain cancer	0.000345	0.000804	CcSEcCtD
Tacrolimus—Jaundice—Etoposide—brain cancer	0.000344	0.000803	CcSEcCtD
Tacrolimus—Stomatitis—Etoposide—brain cancer	0.000344	0.000803	CcSEcCtD
Tacrolimus—ABCB1—endocrine gland—brain cancer	0.000344	0.00193	CbGeAlD
Tacrolimus—Anorexia—Hydroxyurea—brain cancer	0.000344	0.000801	CcSEcCtD
Tacrolimus—Hypersensitivity—Procarbazine—brain cancer	0.000343	0.0008	CcSEcCtD
Tacrolimus—ABCB1—head—brain cancer	0.00034	0.0019	CbGeAlD
Tacrolimus—Dysgeusia—Temozolomide—brain cancer	0.000338	0.000788	CcSEcCtD
Tacrolimus—Vision blurred—Carmustine—brain cancer	0.000336	0.000785	CcSEcCtD
Tacrolimus—Tremor—Carmustine—brain cancer	0.000334	0.00078	CcSEcCtD
Tacrolimus—Asthenia—Procarbazine—brain cancer	0.000334	0.000779	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Etoposide—brain cancer	0.000334	0.000779	CcSEcCtD
Tacrolimus—Back pain—Temozolomide—brain cancer	0.000334	0.000778	CcSEcCtD
Tacrolimus—Anaemia—Carmustine—brain cancer	0.00033	0.000769	CcSEcCtD
Tacrolimus—Agranulocytosis—Etoposide—brain cancer	0.00033	0.000769	CcSEcCtD
Tacrolimus—Pruritus—Procarbazine—brain cancer	0.000329	0.000768	CcSEcCtD
Tacrolimus—Agitation—Carmustine—brain cancer	0.000328	0.000765	CcSEcCtD
Tacrolimus—Vision blurred—Temozolomide—brain cancer	0.000325	0.000758	CcSEcCtD
Tacrolimus—Tremor—Temozolomide—brain cancer	0.000323	0.000754	CcSEcCtD
Tacrolimus—Dyspnoea—Hydroxyurea—brain cancer	0.000321	0.000749	CcSEcCtD
Tacrolimus—Somnolence—Hydroxyurea—brain cancer	0.00032	0.000747	CcSEcCtD
Tacrolimus—Ill-defined disorder—Temozolomide—brain cancer	0.00032	0.000746	CcSEcCtD
Tacrolimus—Leukopenia—Carmustine—brain cancer	0.00032	0.000745	CcSEcCtD
Tacrolimus—Anaemia—Temozolomide—brain cancer	0.000319	0.000744	CcSEcCtD
Tacrolimus—Diarrhoea—Procarbazine—brain cancer	0.000319	0.000743	CcSEcCtD
Tacrolimus—Dyspepsia—Hydroxyurea—brain cancer	0.000317	0.00074	CcSEcCtD
Tacrolimus—Agitation—Temozolomide—brain cancer	0.000317	0.000739	CcSEcCtD
Tacrolimus—Hypoaesthesia—Etoposide—brain cancer	0.000316	0.000736	CcSEcCtD
Tacrolimus—Decreased appetite—Hydroxyurea—brain cancer	0.000313	0.000731	CcSEcCtD
Tacrolimus—Urinary tract disorder—Etoposide—brain cancer	0.000313	0.00073	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000311	0.000726	CcSEcCtD
Tacrolimus—Malaise—Temozolomide—brain cancer	0.000311	0.000725	CcSEcCtD
Tacrolimus—Urethral disorder—Etoposide—brain cancer	0.000311	0.000725	CcSEcCtD
Tacrolimus—Fatigue—Hydroxyurea—brain cancer	0.000311	0.000725	CcSEcCtD
Tacrolimus—Vertigo—Temozolomide—brain cancer	0.00031	0.000723	CcSEcCtD
Tacrolimus—ABCB1—central nervous system—brain cancer	0.00031	0.00174	CbGeAlD
Tacrolimus—Convulsion—Carmustine—brain cancer	0.000309	0.000721	CcSEcCtD
Tacrolimus—Leukopenia—Temozolomide—brain cancer	0.000309	0.00072	CcSEcCtD
Tacrolimus—Hypertension—Carmustine—brain cancer	0.000308	0.000719	CcSEcCtD
Tacrolimus—Constipation—Hydroxyurea—brain cancer	0.000308	0.000719	CcSEcCtD
Tacrolimus—Pain—Hydroxyurea—brain cancer	0.000308	0.000719	CcSEcCtD
Tacrolimus—Dizziness—Procarbazine—brain cancer	0.000308	0.000718	CcSEcCtD
Tacrolimus—Palpitations—Temozolomide—brain cancer	0.000305	0.000711	CcSEcCtD
Tacrolimus—Chest pain—Carmustine—brain cancer	0.000304	0.000709	CcSEcCtD
Tacrolimus—Myalgia—Carmustine—brain cancer	0.000304	0.000709	CcSEcCtD
Tacrolimus—ABCB1—cerebellum—brain cancer	0.000303	0.0017	CbGeAlD
Tacrolimus—Anxiety—Carmustine—brain cancer	0.000303	0.000706	CcSEcCtD
Tacrolimus—Cough—Temozolomide—brain cancer	0.000301	0.000702	CcSEcCtD
Tacrolimus—Erythema multiforme—Etoposide—brain cancer	0.0003	0.000699	CcSEcCtD
Tacrolimus—Convulsion—Temozolomide—brain cancer	0.000299	0.000697	CcSEcCtD
Tacrolimus—Hypertension—Temozolomide—brain cancer	0.000298	0.000695	CcSEcCtD
Tacrolimus—Feeling abnormal—Hydroxyurea—brain cancer	0.000297	0.000693	CcSEcCtD
Tacrolimus—Eye disorder—Etoposide—brain cancer	0.000296	0.000691	CcSEcCtD
Tacrolimus—Vomiting—Procarbazine—brain cancer	0.000296	0.00069	CcSEcCtD
Tacrolimus—Cardiac disorder—Etoposide—brain cancer	0.000294	0.000686	CcSEcCtD
Tacrolimus—Flushing—Etoposide—brain cancer	0.000294	0.000686	CcSEcCtD
Tacrolimus—Confusional state—Carmustine—brain cancer	0.000294	0.000685	CcSEcCtD
Tacrolimus—Myalgia—Temozolomide—brain cancer	0.000294	0.000685	CcSEcCtD
Tacrolimus—Arthralgia—Temozolomide—brain cancer	0.000294	0.000685	CcSEcCtD
Tacrolimus—Rash—Procarbazine—brain cancer	0.000294	0.000685	CcSEcCtD
Tacrolimus—Dermatitis—Procarbazine—brain cancer	0.000293	0.000684	CcSEcCtD
Tacrolimus—Anxiety—Temozolomide—brain cancer	0.000293	0.000683	CcSEcCtD
Tacrolimus—Headache—Procarbazine—brain cancer	0.000292	0.00068	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000292	0.00068	CcSEcCtD
Tacrolimus—Oedema—Carmustine—brain cancer	0.000291	0.000679	CcSEcCtD
Tacrolimus—Discomfort—Temozolomide—brain cancer	0.00029	0.000677	CcSEcCtD
Tacrolimus—Infection—Carmustine—brain cancer	0.000289	0.000675	CcSEcCtD
Tacrolimus—Angiopathy—Etoposide—brain cancer	0.000288	0.000671	CcSEcCtD
Tacrolimus—Dry mouth—Temozolomide—brain cancer	0.000287	0.00067	CcSEcCtD
Tacrolimus—Immune system disorder—Etoposide—brain cancer	0.000286	0.000668	CcSEcCtD
Tacrolimus—Mediastinal disorder—Etoposide—brain cancer	0.000286	0.000666	CcSEcCtD
Tacrolimus—Thrombocytopenia—Carmustine—brain cancer	0.000285	0.000665	CcSEcCtD
Tacrolimus—Body temperature increased—Hydroxyurea—brain cancer	0.000285	0.000664	CcSEcCtD
Tacrolimus—Chills—Etoposide—brain cancer	0.000285	0.000664	CcSEcCtD
Tacrolimus—Tachycardia—Carmustine—brain cancer	0.000284	0.000663	CcSEcCtD
Tacrolimus—Confusional state—Temozolomide—brain cancer	0.000284	0.000662	CcSEcCtD
Tacrolimus—Anaphylactic shock—Temozolomide—brain cancer	0.000282	0.000657	CcSEcCtD
Tacrolimus—Oedema—Temozolomide—brain cancer	0.000282	0.000657	CcSEcCtD
Tacrolimus—Alopecia—Etoposide—brain cancer	0.00028	0.000653	CcSEcCtD
Tacrolimus—Infection—Temozolomide—brain cancer	0.00028	0.000652	CcSEcCtD
Tacrolimus—Anorexia—Carmustine—brain cancer	0.000278	0.000648	CcSEcCtD
Tacrolimus—Nausea—Procarbazine—brain cancer	0.000277	0.000645	CcSEcCtD
Tacrolimus—Nervous system disorder—Temozolomide—brain cancer	0.000276	0.000644	CcSEcCtD
Tacrolimus—Thrombocytopenia—Temozolomide—brain cancer	0.000276	0.000643	CcSEcCtD
Tacrolimus—Skin disorder—Temozolomide—brain cancer	0.000273	0.000638	CcSEcCtD
Tacrolimus—Hypotension—Carmustine—brain cancer	0.000272	0.000635	CcSEcCtD
Tacrolimus—Hyperhidrosis—Temozolomide—brain cancer	0.000272	0.000635	CcSEcCtD
Tacrolimus—Dysgeusia—Etoposide—brain cancer	0.00027	0.00063	CcSEcCtD
Tacrolimus—Anorexia—Temozolomide—brain cancer	0.000268	0.000626	CcSEcCtD
Tacrolimus—Back pain—Etoposide—brain cancer	0.000267	0.000623	CcSEcCtD
Tacrolimus—Hypersensitivity—Hydroxyurea—brain cancer	0.000266	0.000619	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Carmustine—brain cancer	0.000265	0.000619	CcSEcCtD
Tacrolimus—Muscle spasms—Etoposide—brain cancer	0.000265	0.000619	CcSEcCtD
Tacrolimus—Insomnia—Carmustine—brain cancer	0.000264	0.000614	CcSEcCtD
Tacrolimus—Paraesthesia—Carmustine—brain cancer	0.000262	0.00061	CcSEcCtD
Tacrolimus—Dyspnoea—Carmustine—brain cancer	0.00026	0.000606	CcSEcCtD
Tacrolimus—Somnolence—Carmustine—brain cancer	0.000259	0.000604	CcSEcCtD
Tacrolimus—Asthenia—Hydroxyurea—brain cancer	0.000259	0.000603	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000257	0.000598	CcSEcCtD
Tacrolimus—Ill-defined disorder—Etoposide—brain cancer	0.000256	0.000597	CcSEcCtD
Tacrolimus—Anaemia—Etoposide—brain cancer	0.000255	0.000595	CcSEcCtD
Tacrolimus—Insomnia—Temozolomide—brain cancer	0.000255	0.000594	CcSEcCtD
Tacrolimus—Decreased appetite—Carmustine—brain cancer	0.000253	0.000591	CcSEcCtD
Tacrolimus—Paraesthesia—Temozolomide—brain cancer	0.000253	0.00059	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Carmustine—brain cancer	0.000252	0.000587	CcSEcCtD
Tacrolimus—Dyspnoea—Temozolomide—brain cancer	0.000251	0.000585	CcSEcCtD
Tacrolimus—Somnolence—Temozolomide—brain cancer	0.00025	0.000584	CcSEcCtD
Tacrolimus—Constipation—Carmustine—brain cancer	0.000249	0.000581	CcSEcCtD
Tacrolimus—Pain—Carmustine—brain cancer	0.000249	0.000581	CcSEcCtD
Tacrolimus—Malaise—Etoposide—brain cancer	0.000249	0.000581	CcSEcCtD
Tacrolimus—Vertigo—Etoposide—brain cancer	0.000248	0.000578	CcSEcCtD
Tacrolimus—Dyspepsia—Temozolomide—brain cancer	0.000248	0.000578	CcSEcCtD
Tacrolimus—Leukopenia—Etoposide—brain cancer	0.000247	0.000576	CcSEcCtD
Tacrolimus—Diarrhoea—Hydroxyurea—brain cancer	0.000247	0.000575	CcSEcCtD
Tacrolimus—ABCB1—brain—brain cancer	0.000246	0.00138	CbGeAlD
Tacrolimus—Decreased appetite—Temozolomide—brain cancer	0.000245	0.000571	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Temozolomide—brain cancer	0.000243	0.000567	CcSEcCtD
Tacrolimus—Fatigue—Temozolomide—brain cancer	0.000243	0.000566	CcSEcCtD
Tacrolimus—Loss of consciousness—Etoposide—brain cancer	0.000243	0.000566	CcSEcCtD
Tacrolimus—Cough—Etoposide—brain cancer	0.000241	0.000562	CcSEcCtD
Tacrolimus—Pain—Temozolomide—brain cancer	0.000241	0.000561	CcSEcCtD
Tacrolimus—Constipation—Temozolomide—brain cancer	0.000241	0.000561	CcSEcCtD
Tacrolimus—Feeling abnormal—Carmustine—brain cancer	0.00024	0.00056	CcSEcCtD
Tacrolimus—Convulsion—Etoposide—brain cancer	0.000239	0.000558	CcSEcCtD
Tacrolimus—Hypertension—Etoposide—brain cancer	0.000238	0.000556	CcSEcCtD
Tacrolimus—Dizziness—Hydroxyurea—brain cancer	0.000238	0.000556	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Carmustine—brain cancer	0.000238	0.000556	CcSEcCtD
Tacrolimus—Chest pain—Etoposide—brain cancer	0.000235	0.000548	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000233	0.000544	CcSEcCtD
Tacrolimus—Discomfort—Etoposide—brain cancer	0.000232	0.000541	CcSEcCtD
Tacrolimus—Feeling abnormal—Temozolomide—brain cancer	0.000232	0.000541	CcSEcCtD
Tacrolimus—Abdominal pain—Carmustine—brain cancer	0.00023	0.000537	CcSEcCtD
Tacrolimus—Body temperature increased—Carmustine—brain cancer	0.00023	0.000537	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Temozolomide—brain cancer	0.00023	0.000537	CcSEcCtD
Tacrolimus—Vomiting—Hydroxyurea—brain cancer	0.000229	0.000534	CcSEcCtD
Tacrolimus—Rash—Hydroxyurea—brain cancer	0.000227	0.00053	CcSEcCtD
Tacrolimus—Confusional state—Etoposide—brain cancer	0.000227	0.00053	CcSEcCtD
Tacrolimus—Dermatitis—Hydroxyurea—brain cancer	0.000227	0.000529	CcSEcCtD
Tacrolimus—Headache—Hydroxyurea—brain cancer	0.000226	0.000526	CcSEcCtD
Tacrolimus—Anaphylactic shock—Etoposide—brain cancer	0.000225	0.000525	CcSEcCtD
Tacrolimus—Infection—Etoposide—brain cancer	0.000224	0.000522	CcSEcCtD
Tacrolimus—Urticaria—Temozolomide—brain cancer	0.000224	0.000522	CcSEcCtD
Tacrolimus—Body temperature increased—Temozolomide—brain cancer	0.000223	0.000519	CcSEcCtD
Tacrolimus—Abdominal pain—Temozolomide—brain cancer	0.000223	0.000519	CcSEcCtD
Tacrolimus—Thrombocytopenia—Etoposide—brain cancer	0.000221	0.000514	CcSEcCtD
Tacrolimus—Tachycardia—Etoposide—brain cancer	0.00022	0.000513	CcSEcCtD
Tacrolimus—Skin disorder—Etoposide—brain cancer	0.000219	0.00051	CcSEcCtD
Tacrolimus—Hyperhidrosis—Etoposide—brain cancer	0.000218	0.000508	CcSEcCtD
Tacrolimus—Anorexia—Etoposide—brain cancer	0.000215	0.000501	CcSEcCtD
Tacrolimus—Hypersensitivity—Carmustine—brain cancer	0.000215	0.000501	CcSEcCtD
Tacrolimus—Nausea—Hydroxyurea—brain cancer	0.000214	0.000499	CcSEcCtD
Tacrolimus—Hypotension—Etoposide—brain cancer	0.000211	0.000491	CcSEcCtD
Tacrolimus—Asthenia—Carmustine—brain cancer	0.000209	0.000487	CcSEcCtD
Tacrolimus—Hypersensitivity—Temozolomide—brain cancer	0.000207	0.000484	CcSEcCtD
Tacrolimus—Paraesthesia—Etoposide—brain cancer	0.000202	0.000472	CcSEcCtD
Tacrolimus—Asthenia—Temozolomide—brain cancer	0.000202	0.000471	CcSEcCtD
Tacrolimus—Dyspnoea—Etoposide—brain cancer	0.000201	0.000468	CcSEcCtD
Tacrolimus—Somnolence—Etoposide—brain cancer	0.0002	0.000467	CcSEcCtD
Tacrolimus—Diarrhoea—Carmustine—brain cancer	0.000199	0.000465	CcSEcCtD
Tacrolimus—Pruritus—Temozolomide—brain cancer	0.000199	0.000464	CcSEcCtD
Tacrolimus—Decreased appetite—Etoposide—brain cancer	0.000196	0.000457	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Etoposide—brain cancer	0.000195	0.000454	CcSEcCtD
Tacrolimus—Fatigue—Etoposide—brain cancer	0.000194	0.000453	CcSEcCtD
Tacrolimus—Dizziness—Carmustine—brain cancer	0.000193	0.000449	CcSEcCtD
Tacrolimus—Pain—Etoposide—brain cancer	0.000193	0.000449	CcSEcCtD
Tacrolimus—Constipation—Etoposide—brain cancer	0.000193	0.000449	CcSEcCtD
Tacrolimus—Diarrhoea—Temozolomide—brain cancer	0.000193	0.000449	CcSEcCtD
Tacrolimus—Dizziness—Temozolomide—brain cancer	0.000186	0.000434	CcSEcCtD
Tacrolimus—Feeling abnormal—Etoposide—brain cancer	0.000186	0.000433	CcSEcCtD
Tacrolimus—Vomiting—Carmustine—brain cancer	0.000185	0.000432	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Etoposide—brain cancer	0.000184	0.00043	CcSEcCtD
Tacrolimus—Rash—Carmustine—brain cancer	0.000184	0.000428	CcSEcCtD
Tacrolimus—Dermatitis—Carmustine—brain cancer	0.000184	0.000428	CcSEcCtD
Tacrolimus—Headache—Carmustine—brain cancer	0.000183	0.000426	CcSEcCtD
Tacrolimus—Vomiting—Temozolomide—brain cancer	0.000179	0.000417	CcSEcCtD
Tacrolimus—Urticaria—Etoposide—brain cancer	0.000179	0.000417	CcSEcCtD
Tacrolimus—Abdominal pain—Etoposide—brain cancer	0.000178	0.000415	CcSEcCtD
Tacrolimus—Body temperature increased—Etoposide—brain cancer	0.000178	0.000415	CcSEcCtD
Tacrolimus—Rash—Temozolomide—brain cancer	0.000178	0.000414	CcSEcCtD
Tacrolimus—Dermatitis—Temozolomide—brain cancer	0.000177	0.000414	CcSEcCtD
Tacrolimus—Headache—Temozolomide—brain cancer	0.000176	0.000411	CcSEcCtD
Tacrolimus—Nausea—Carmustine—brain cancer	0.000173	0.000404	CcSEcCtD
Tacrolimus—Nausea—Temozolomide—brain cancer	0.000167	0.00039	CcSEcCtD
Tacrolimus—Hypersensitivity—Etoposide—brain cancer	0.000166	0.000387	CcSEcCtD
Tacrolimus—Asthenia—Etoposide—brain cancer	0.000162	0.000377	CcSEcCtD
Tacrolimus—Pruritus—Etoposide—brain cancer	0.000159	0.000372	CcSEcCtD
Tacrolimus—Diarrhoea—Etoposide—brain cancer	0.000154	0.000359	CcSEcCtD
Tacrolimus—Dizziness—Etoposide—brain cancer	0.000149	0.000347	CcSEcCtD
Tacrolimus—Vomiting—Etoposide—brain cancer	0.000143	0.000334	CcSEcCtD
Tacrolimus—Rash—Etoposide—brain cancer	0.000142	0.000331	CcSEcCtD
Tacrolimus—Dermatitis—Etoposide—brain cancer	0.000142	0.000331	CcSEcCtD
Tacrolimus—Headache—Etoposide—brain cancer	0.000141	0.000329	CcSEcCtD
Tacrolimus—Nausea—Etoposide—brain cancer	0.000134	0.000312	CcSEcCtD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000126	0.000677	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TRPC6—brain cancer	0.000126	0.000676	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—STAT3—brain cancer	0.000124	0.00067	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—RELA—brain cancer	0.000124	0.000667	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SMO—brain cancer	0.000124	0.000665	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTCH1—brain cancer	0.000124	0.000665	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—ERBB2—brain cancer	0.000123	0.000663	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000123	0.000659	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—brain cancer	0.000122	0.000658	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HEY1—brain cancer	0.000121	0.000652	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—BSG—brain cancer	0.000121	0.000652	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000121	0.000651	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.00012	0.000644	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PDGFRA—brain cancer	0.000119	0.000642	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—DLL1—brain cancer	0.000119	0.000639	CbGpPWpGaD
Tacrolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000118	0.000634	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HES1—brain cancer	0.000116	0.000622	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000115	0.000621	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—EGFR—brain cancer	0.000115	0.000619	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—STAT3—brain cancer	0.000114	0.000612	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000113	0.000609	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000111	0.000599	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTCH2—brain cancer	0.00011	0.000594	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PDGFRA—brain cancer	0.00011	0.000592	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—EGFR—brain cancer	0.00011	0.000592	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—VAV1—brain cancer	0.000109	0.000587	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000109	0.000586	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—EGFR—brain cancer	0.000108	0.000583	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CTNNB1—brain cancer	0.000108	0.00058	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HES5—brain cancer	0.000107	0.000575	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—STAT3—brain cancer	0.000106	0.000568	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN2A—brain cancer	0.000105	0.000565	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—VAV1—brain cancer	0.000105	0.000563	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IRS2—brain cancer	0.000105	0.000563	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—VAV1—brain cancer	0.000104	0.000561	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STRADA—brain cancer	0.000104	0.000558	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—EGFR—brain cancer	0.000103	0.000557	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000103	0.000556	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—STAT3—brain cancer	0.000103	0.000555	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—EGFR—brain cancer	0.000103	0.000554	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000103	0.000554	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL2—brain cancer	0.000103	0.000554	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IDH1—brain cancer	0.000103	0.000552	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—EGFR—brain cancer	0.000102	0.000551	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—EGFR—brain cancer	0.000102	0.000548	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000101	0.000545	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—PIK3CG—brain cancer	0.000101	0.000544	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—RELA—brain cancer	0.000101	0.000544	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SHH—brain cancer	0.000101	0.000544	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000101	0.000543	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	0.0001	0.000541	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.0001	0.000539	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—VEGFA—brain cancer	9.88e-05	0.000532	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOTCH2—brain cancer	9.88e-05	0.000531	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TRPC6—brain cancer	9.74e-05	0.000524	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HEY1—brain cancer	9.73e-05	0.000524	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IRS2—brain cancer	9.67e-05	0.00052	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—EGFR—brain cancer	9.59e-05	0.000516	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	9.59e-05	0.000516	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—EGFR—brain cancer	9.59e-05	0.000516	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTCH1—brain cancer	9.58e-05	0.000515	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SMO—brain cancer	9.58e-05	0.000515	CbGpPWpGaD
Tacrolimus—MTOR—Disease—DLL1—brain cancer	9.54e-05	0.000513	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—EGFR—brain cancer	9.5e-05	0.000511	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.49e-05	0.00051	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—RELA—brain cancer	9.48e-05	0.00051	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—ERBB2—brain cancer	9.42e-05	0.000507	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—brain cancer	9.42e-05	0.000507	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	9.41e-05	0.000507	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VAV1—brain cancer	9.41e-05	0.000507	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—EGFR—brain cancer	9.38e-05	0.000505	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	9.34e-05	0.000503	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.31e-05	0.000501	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2C9—brain cancer	9.28e-05	0.000499	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—brain cancer	9.14e-05	0.000492	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HES1—brain cancer	8.97e-05	0.000482	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PDGFRA—brain cancer	8.93e-05	0.00048	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—EGFR—brain cancer	8.87e-05	0.000477	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.87e-05	0.000477	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—VEGFA—brain cancer	8.75e-05	0.000471	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—brain cancer	8.71e-05	0.000469	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ABR—brain cancer	8.66e-05	0.000466	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PDGFRA—brain cancer	8.57e-05	0.000461	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—EGFR—brain cancer	8.54e-05	0.00046	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APC—brain cancer	8.54e-05	0.000459	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PDGFRA—brain cancer	8.54e-05	0.000459	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	8.49e-05	0.000457	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GLI2—brain cancer	8.36e-05	0.00045	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—SKP2—brain cancer	8.33e-05	0.000448	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ENO2—brain cancer	8.12e-05	0.000437	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SHH—brain cancer	8.12e-05	0.000437	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HES1—brain cancer	8.1e-05	0.000436	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TRPC6—brain cancer	7.94e-05	0.000427	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—BSG—brain cancer	7.89e-05	0.000425	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GLI1—brain cancer	7.86e-05	0.000423	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IRS2—brain cancer	7.84e-05	0.000422	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—VEGFA—brain cancer	7.74e-05	0.000416	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PDGFRA—brain cancer	7.71e-05	0.000415	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.67e-05	0.000413	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—STAT3—brain cancer	7.66e-05	0.000412	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOTCH2—brain cancer	7.66e-05	0.000412	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—IRS2—brain cancer	7.53e-05	0.000405	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IRS2—brain cancer	7.49e-05	0.000403	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SPP1—brain cancer	7.48e-05	0.000403	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SUFU—brain cancer	7.45e-05	0.000401	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	7.33e-05	0.000394	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VAV1—brain cancer	7.3e-05	0.000393	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—RELA—brain cancer	7.22e-05	0.000389	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.22e-05	0.000388	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GFAP—brain cancer	7.19e-05	0.000387	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—STAT3—brain cancer	7.19e-05	0.000387	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ERBB2—brain cancer	7.18e-05	0.000386	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—brain cancer	7.12e-05	0.000383	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	6.87e-05	0.00037	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HEY1—brain cancer	6.82e-05	0.000367	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—IDH1—brain cancer	6.79e-05	0.000365	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IRS2—brain cancer	6.77e-05	0.000364	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2C9—brain cancer	6.71e-05	0.000361	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DLL1—brain cancer	6.68e-05	0.00036	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ERBB2—brain cancer	6.63e-05	0.000357	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APC—brain cancer	6.62e-05	0.000356	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—EGFR—brain cancer	6.53e-05	0.000351	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—brain cancer	6.51e-05	0.00035	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—VAV1—brain cancer	6.35e-05	0.000342	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CTNNB1—brain cancer	6.28e-05	0.000338	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HES1—brain cancer	6.28e-05	0.000338	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.02e-05	0.000324	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APC—brain cancer	5.98e-05	0.000322	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PDGFRA—brain cancer	5.98e-05	0.000322	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PIK3CG—brain cancer	5.98e-05	0.000322	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VAV1—brain cancer	5.95e-05	0.00032	CbGpPWpGaD
Tacrolimus—MTOR—Disease—VAV1—brain cancer	5.86e-05	0.000315	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—brain cancer	5.85e-05	0.000315	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SPP1—brain cancer	5.8e-05	0.000312	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CTNNB1—brain cancer	5.8e-05	0.000312	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2C9—brain cancer	5.78e-05	0.000311	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—BSG—brain cancer	5.7e-05	0.000307	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SHH—brain cancer	5.68e-05	0.000306	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.6e-05	0.000302	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TRPC6—brain cancer	5.48e-05	0.000295	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—STAT3—brain cancer	5.48e-05	0.000295	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EGFR—brain cancer	5.45e-05	0.000293	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—RELA—brain cancer	5.41e-05	0.000291	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTCH1—brain cancer	5.39e-05	0.00029	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMO—brain cancer	5.39e-05	0.00029	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB2—brain cancer	5.38e-05	0.000289	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ENO2—brain cancer	5.36e-05	0.000289	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IRS2—brain cancer	5.25e-05	0.000282	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PDGFRA—brain cancer	5.2e-05	0.00028	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—RELA—brain cancer	5.19e-05	0.000279	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB2—brain cancer	5.16e-05	0.000278	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	5.16e-05	0.000278	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB2—brain cancer	5.14e-05	0.000277	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2C9—brain cancer	5.06e-05	0.000272	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—STAT3—brain cancer	5.06e-05	0.000272	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HES1—brain cancer	5.04e-05	0.000271	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EGFR—brain cancer	4.98e-05	0.000268	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.95e-05	0.000266	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—BSG—brain cancer	4.91e-05	0.000264	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—IDH1—brain cancer	4.91e-05	0.000264	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.9e-05	0.000264	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PDGFRA—brain cancer	4.8e-05	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CTNNB1—brain cancer	4.7e-05	0.000253	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MYC—brain cancer	4.7e-05	0.000253	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RELA—brain cancer	4.67e-05	0.000251	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB2—brain cancer	4.64e-05	0.00025	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APC—brain cancer	4.64e-05	0.000249	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CG—brain cancer	4.64e-05	0.000249	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EGFR—brain cancer	4.59e-05	0.000247	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IRS2—brain cancer	4.57e-05	0.000246	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CTNNB1—brain cancer	4.5e-05	0.000242	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.38e-05	0.000236	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.32e-05	0.000232	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOTCH2—brain cancer	4.31e-05	0.000232	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—BSG—brain cancer	4.3e-05	0.000232	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—IDH1—brain cancer	4.22e-05	0.000227	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IRS2—brain cancer	4.22e-05	0.000227	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—brain cancer	4.21e-05	0.000226	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VAV1—brain cancer	4.11e-05	0.000221	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCND1—brain cancer	4.1e-05	0.000221	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CTNNB1—brain cancer	4.06e-05	0.000218	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.97e-05	0.000214	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—STAT3—brain cancer	3.92e-05	0.000211	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.88e-05	0.000209	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ENO2—brain cancer	3.88e-05	0.000209	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CG—brain cancer	3.78e-05	0.000203	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EGFR—brain cancer	3.73e-05	0.0002	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APC—brain cancer	3.72e-05	0.0002	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—IDH1—brain cancer	3.7e-05	0.000199	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MYC—brain cancer	3.64e-05	0.000196	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RELA—brain cancer	3.62e-05	0.000195	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB2—brain cancer	3.6e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—EGFR—brain cancer	3.58e-05	0.000192	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—brain cancer	3.58e-05	0.000192	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EGFR—brain cancer	3.56e-05	0.000192	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—STAT3—brain cancer	3.54e-05	0.00019	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HES1—brain cancer	3.53e-05	0.00019	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.44e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PDGFRA—brain cancer	3.36e-05	0.000181	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ENO2—brain cancer	3.34e-05	0.00018	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MYC—brain cancer	3.29e-05	0.000177	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SPP1—brain cancer	3.26e-05	0.000176	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—brain cancer	3.26e-05	0.000175	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.26e-05	0.000175	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EGFR—brain cancer	3.22e-05	0.000173	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCND1—brain cancer	3.18e-05	0.000171	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RELA—brain cancer	3.15e-05	0.00017	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CTNNB1—brain cancer	3.15e-05	0.000169	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB2—brain cancer	3.13e-05	0.000168	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2C9—brain cancer	3.12e-05	0.000168	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS2—brain cancer	2.95e-05	0.000159	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ENO2—brain cancer	2.93e-05	0.000157	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB2—brain cancer	2.89e-05	0.000156	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—brain cancer	2.84e-05	0.000153	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—brain cancer	2.77e-05	0.000149	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—STAT3—brain cancer	2.74e-05	0.000148	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTNNB1—brain cancer	2.74e-05	0.000147	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—brain cancer	2.7e-05	0.000145	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—brain cancer	2.66e-05	0.000143	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—BSG—brain cancer	2.65e-05	0.000143	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APC—brain cancer	2.61e-05	0.00014	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CG—brain cancer	2.61e-05	0.00014	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MYC—brain cancer	2.55e-05	0.000137	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CTNNB1—brain cancer	2.53e-05	0.000136	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGFR—brain cancer	2.49e-05	0.000134	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CG—brain cancer	2.46e-05	0.000132	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT3—brain cancer	2.39e-05	0.000128	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—IDH1—brain cancer	2.28e-05	0.000123	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—brain cancer	2.26e-05	0.000122	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT3—brain cancer	2.2e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGFR—brain cancer	2.17e-05	0.000117	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—brain cancer	2.09e-05	0.000113	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MYC—brain cancer	2.05e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RELA—brain cancer	2.04e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB2—brain cancer	2.02e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGFR—brain cancer	2e-05	0.000108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—brain cancer	1.83e-05	9.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ENO2—brain cancer	1.8e-05	9.7e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCND1—brain cancer	1.79e-05	9.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CG—brain cancer	1.78e-05	9.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CTNNB1—brain cancer	1.77e-05	9.53e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—brain cancer	1.71e-05	9.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—brain cancer	1.56e-05	8.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT3—brain cancer	1.54e-05	8.31e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CG—brain cancer	1.53e-05	8.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MYC—brain cancer	1.43e-05	7.72e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGFR—brain cancer	1.4e-05	7.55e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CG—brain cancer	1.34e-05	7.22e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—brain cancer	1.18e-05	6.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CG—brain cancer	8.27e-06	4.45e-05	CbGpPWpGaD
